Clinical trial
Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)
The purpose of this study is to determine whether raltegravir is effective in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium- enhanced MRI.
| Category | Value |
|---|---|
| Study start date | 2013-01-07 |